Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr-Jun;12(2):150-156.
doi: 10.4103/ccd.ccd_101_20. Epub 2021 Jun 14.

Clinical and Radiographic Analysis of Novabone Putty with Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Randomized Control Trial

Vibhor Hazari  1 , Anushree Choudhary  1 , Rohit Mishra  1 , Kabbur Thipanna Chandrashekar  1 , Ashima Trivedi  1 , Pranshu Kumar Pathak  2
Affiliations

Clinical and Radiographic Analysis of Novabone Putty with Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Randomized Control Trial

Vibhor Hazari et al. Contemp Clin Dent. 2021 Apr-Jun.

Abstract

Background: Periodontal regeneration remains one of the crucial issues in the field of periodontology. Periodontal intrabony defects could be treated by surgical intervention through various alloplastic bone graft substitutes. The Food and Drug Administration approved, Novabone putty is one of the recently marketed bone graft substitutes, which has been used in the present study. This study also incorporates the placement of platelet-rich fibrin (PRF) in combination with Novabone putty.

Materials and methods: Twenty patients were included in the study and were allocated to either Group A or Group B through randomization. Group A included the placement of Novabone putty in the periodontal intrabony defects, whereas Group B included the placement of Novabone putty along with PRF. Statistical analysis of plaque index, gingival index, probing pocket depth, relative attachment level, and intraoral periapical radiographs was performed.

Results: Statistical more significant difference (P < 0.05) in probing pocket depth, and relative attachment level was observed in Group B (Novabone putty and PRF) in comparison to Group A (Novabone putty).

Conclusion: Evaluation of efficacy of Novabone putty along with PRF produced more favorable results in relative attachment level gain and more reduction in probing pocket depth when compared to Novabone putty alone.

Keywords: Chronic periodontitis; novabone putty; platelet-rich fibrin.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Novabone putty
Figure 2
Figure 2
Probing pocket depth measurement using UNC-15 probe with occlusal stent
Figure 3
Figure 3
Prepared platelet rich fibrin
Figure 4
Figure 4
(a) Open flap debridement (Group A). (b) Placement of Novabone putty (Group A)
Figure 5
Figure 5
(a) Open flap debridement (Group B). (b) Placement of Novabone putty with platelet rich fibrin (Group B)
Figure 6
Figure 6
(a) Sutures given (b) periodontal dressing given
Figure 7
Figure 7
Radiographs of Group A (a) at baseline (b) at 3 months (c) at 6 months
Figure 8
Figure 8
Radiographs of Group B (a) at baseline (b) at 3 months (c) at 6 months
Graph 1
Graph 1
Plaque and gingival index values at different time intervals in both groups
Graph 2
Graph 2
Different index values at different time intervals in both groups
See this image and copyright information in PMC

References

    1. American Academy of Periodontology, editor. Glossary of Periodontal Terms. American Academy of Periodontology. 2001
    1. Hanes PJ. Bone replacement grafts for the treatment of periodontal intrabony defects. Oral Maxillofac Surg Clin North Am. 2007;19:499–512,VI. - PubMed
    1. Lovelace TB, Mellonig JT, Meffert RM, Jones AA, Nummikoski PV, Cochran DL. Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans. J Periodontol. 1998;69:1027–35. - PubMed
    1. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol. 1997;68:1186–93. - PubMed
    1. Dohan DM, choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e37–44. - PubMed